|1 month supply including consultation||£100|
|3 months’ supply including consultation||£250|
- WHAT ARE THE INDICATIONS FOR BIMATOPROST TREATMENT?
- HOW DOES IT WORK?
- WHY DON’T YOU SUPPLY LATISSE?
- HOW LONG DO I NEED TO USE THE SERUM TO SEE AN EFFECT?
- WHAT ARE THE RISKS AND POSSIBLE SIDE EFFECTS OF USING LUMIGAN?
- WHAT IF I WEAR CONTACT LENSES?
- WHAT HAPPENS IF I STOP USING THE SERUM?
- HOW DO I APPLY THE SERUM?
- WHAT ARE THE CONTRAINDICATIONS OF USING LUMIGAN?
Bimatoprost is the generic drug name, also known as the brand name Lumigan, which is used as eyedrops to treat glaucoma. Latisse™ is the brand name for the bimatoprost-based medication that gained FDA approval in the US for the treatment of hypotrichosis; clinical trials had found that (on average) eyelashes were 25% longer, 106% thicker and 18% darker. Hypotrichosis is a medical term for short or missing lashes, frequently seen in men and women as they approach middle age. Bimatoprost affects the growth (anagen) phase of the eyelash hair cycle by increasing the length of the growth phase and the number of hairs along the eyelid margin. The onset of action is gradual, with most users noticing a significant improvement in the length and number of their eyelashes by 2 months. If treatment is discontinued, eyelashes will return to their previous appearance over several weeks to months.
Bimatoprost acts on receptors in the hair follicle to stimulate the follicle to enter the growth phase, causing lashes to grow longer and thicker.
Latisse™ is the brand name in the US for the bimatoprost 0.03% solution with FDA approval. Latisse is not officially distributed in the UK. At The Clinic Holland Park, we use Lumigan. The ingredient in Lumigan is the same as Latisse (i.e. bimatoprost 0.03% solution).
You will start to notice a gradual increase in the thickness and length of your lashes in the first few weeks of treatment. Full results are seen at around 16 weeks.
The following side effects are the most frequently reported, but occur in less than 4% of users (i.e. 4 out of 100 users):
- Eye irritation and itching
- Conjunctival hyperaemia or red eye (redness of the white, moist covering of the eyeball)
- Dry eye symptoms
- Eyelid redness.
Although rare, bimatoprost has the potential to permanently increase the brown pigmentation of the iris (the coloured part of the eyeball, inside the eye).
Bimatoprost may cause hyperpigmentation or darkening of the eyelid skin, which may or may not be reversible upon discontinuation of the treatment.
Bimatoprost may lower intraocular pressure (IOP) or pressure inside the eye; however, the magnitude of this reduction is usually not a cause for concern.
If you have a history of abnormal eye pressures or glaucoma you should only use bimatoprost under the close supervision of your ophthalmologist.
Inform anyone conducting an eye pressure examination that you are using bimatoprost; and inform your ophthalmologist that you are using bimatoprost if eye surgery is planned.
Do not use Lumigan if you are allergic or hypersensitive to bimatoprost or any other ingredient in this product.
Lumigan is intended for use on the skin at the base of the eyelashes of the upper eyelids only. Do not apply to the lower eyelids as this will increase the chance of side effects such as hyperpigmentation or darkening of the eyelid skin.
Discontinue use of Lumigan and inform your aesthetician immediately if you develop an eye infection, experience any sudden decrease in vision, suffer eye trauma, or develop eye or eyelid reactions.
Contact lenses should be removed before you apply Lumigan to your upper eyelashes, and can be reinserted 30 minutes after application.
Your eyelashes will revert to their original appearance after a period of weeks to months.
Your aesthetics doctor will provide you with applicators and show you how to apply the serum to the base of the upper-lid lashes. The serum is applied once a day.
You should not use Lumigan if:
- you are allergic or hypersensitive to bimatoprost or any other ingredient in this product
- you are about to undergo cataract or other eye procedures
- you have an intraocular inflammation (uveitis)
- you have risk factors for macular oedema
- you have an eye infection
- you have glaucoma or been told that you are at risk of developing glaucoma
- you are under the age of 18
- you are pregnant or breastfeeding.